Roger R. Dmochowski, MD, MMHC, FACS

Dr. Dmochowski is Professor at the Department of Urology, Professor of Surgery, and Professor of Obstetrics and Gynecology at Vanderbilt University in Nashville. He is Director of the Section of Female Pelvic Medicine and program director of the Fellowship in Pelvic Medicine at Vanderbilt. He is Interim Vice President of Surgical Services.   He is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He is Vice Chair, Section of Surgical Sciences Vanderbilt University Medical Center, Associate Director of Quality and Safety, Vanderbilt Health System, Executive Medical Director for Patient Safety and Quality (Surgery), Associate Chief of Staff, and Medical Director of Risk Management at Vanderbilt University Hospital. Dr. Dmochowski is Medical Monitor for the Viveve PURSUIT Trial. 

Dr. Dmochowski received his medical degree from the University of Texas Medical Branch at Galveston. He completed an internship and residency in surgery and urology at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital and Tumor Institute in Texas. In addition, Dr. Dmochowski is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology. He is board certified in urology and female pelvic medicine and reconstruction. He received a Masters in Medical Management from Owen School of Business at Vanderbilt in 2012.  

Dr. Dmochowski has published more than 365 articles, 112 book chapters, and 485 abstracts, and has given over 291 presentations at various national and international meetings. Dr. Dmochowski is on the editorial board for the World Journal of Urology, and he is a reviewer for the Journal of Urology, and Urology. He is the Editor in Chief of Neurourology and Urodynamics. He is a Fellow of the American College of Surgeons and a member of the American Urological Association and International Continence Society. He is a trustee of the American Board of Urology. Dr. Dmochowski has been granted the Zimskind and Lifetime Achievement Awards from the Urodynamics Society for his accomplishment in clinical treatment for incontinence. His current research interests are outcomes of incontinence therapies with a particular emphasis on quality of life issues, patient literacy and informed consent related to pelvic floor interventions. He also is active in bio materials evaluation

Interested in learning more about Viveve's Clinical Evidence?

Click Here to Learn More

Product Indications

Viveve System
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.
Viveve Solutions
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States. The InControl Products (InToneMV) is indicated for the treatment of all forms of urinary incontinence in the United States and Canada.